Month: July 2021

– Industry veterans bring decades of clinical, regulatory and commercial management expertise to VectivBio – – Nominees will stand for election at an Extraordinary General Meeting of shareholders on September 2, 2021 – BASEL, Switzerland, July 12, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions, today announced it has nominated Paul R. Carter and Murray W. Stewart, DM, FRCP, for election as Independent Non-Executive Directors on its Board of Directors. For more than two decades, Mr. Carter and Dr. Stewart have led several global clinical, regulatory and commercial operations in the biopharmaceutical industry. “The start of our...

WILLIAMSVILLE, N.Y., July 12, 2021 (GLOBE NEWSWIRE) — Today, Seneca Resources Company, LLC (“Seneca”), the exploration and production segment of National Fuel Gas Company (NYSE: NFG), and NexTier Oilfield Solutions Inc. (“NexTier”) (NYSE: NEX) announced their intent to pioneer an innovative study evaluating the carbon emissions generated by various types of equipment commonly used for hydraulic fracturing of oil and natural gas wells. The results of this study are expected to provide the industry with a comparative insight on the emissions profile of these technologies, including those utilizing Tier 2 diesel and dynamic gas blending (DGB) engines, Tier 4 diesel and DGB engines, natural gas-powered turbine engines, and electric frac equipment powered by natural gas-fueled reciprocating engines. This carbon emissions assessment...

Amryt to Report Q2 2021 Results and Host Conference Call & Webcast on August 6 DUBLIN, Ireland, and Boston MA, July 12, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that its unaudited financial results for the second quarter 2021 will be released on Friday, August 6, 2021 at 0700 EDT/1200 BST. Amryt will host a conference call and webcast for analysts and investors on August 6 at 0830 EDT/1330 BST. Webcast Player URL: https://edge.media-server.com/mmc/p/kvzqsgbt     Telephone Dial in details: United States  +1 646 787 1226United Kingdom +44 (0) 203 009 5709Ireland  +353 (1) 506 0626   Confirmation Code 3486585A playback facility will be available...

LATHAM, N.Y., July 12, 2021 (GLOBE NEWSWIRE) — Latham Group, Inc. (“Latham” or “the Company”) today announced that the Company was added to the US small-cap Russell 2000 ® Index at the conclusion of the 2021 Russell Indexes annual reconstitution, effective after the U.S. market opened on June 28, 2021. Membership in the US small-cap Russell 2000® index, which remains in place for one year, means automatic inclusion in the U.S. all-cap Russell 3000® Index, as well as the appropriate growth and value style indexes.  “We are excited about Latham’s inclusion in the US small-cap Russell 2000 ® index, as it highlights our ability to generate shareholder value as the largest designer, manufacturer and marketer of in-ground residential swimming pools in North America, Australia and New Zealand,” commented Scott Rajeski, President and Chief...

Models demonstrate substantial overall cost savings for hospitals when using OLINVYK compared to IV morphine in postoperative care CHESTERBROOK, Pa., July 12, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the publication of the health economic model for OLINVYK (oliceridine) injection in Journal of Comparative Effectiveness Research. The model estimates the budget impact of OLINVYK compared to IV morphine when used on-demand in a hospital setting for postoperative pain. The publication is titled, “Cost-effectiveness and Cost-benefit Analysis of Oliceridine in the Treatment of Acute Pain,” with lead author Kit N. Simpson, DrPH, Professor of HealthCare Leadership...

Binding agreement with prominent manufacturer expands supply base and provides access to market-proven electric vehicle (EV) component systems and parts for the ELMS Urban Delivery all-electric cargo van. Segment-defining ELMS Urban Delivery anticipated to be the first Class 1 Commercial EV in the U.S. with production scheduled for later this year. Urban Delivery expected to enter the U.S. market at a starting price of approximately $25,000, after incentives.TROY, Mich., July 12, 2021 (GLOBE NEWSWIRE) — Electric Last Mile Solutions, Inc. (NASDAQ: ELMS) (“ELMS” or “the Company”), a designer of intelligent, e-mobility workstations for the last mile, today announced that it has signed a binding, long-term supply agreement with Liuzhou Wuling Automobile Industry Co., Ltd. (HKSE: 305) (“Wuling Motors”), a supplier of automotive components...

TORONTO, July 12, 2021 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX: YRI; NYSE: AUY; LSE:AUY) (“Yamana” or “the Company”) will announce the results of the Feasibility Study update on the Company’s wholly-owned Wasamac project in the Abitibi-Témiscamingue Region of Quebec, Canada, on Monday, July 19, 2021, after the market close. The Company will hold a separate detailed presentation conference call and webcast relating to the project development on Tuesday, July 20, 2021, from 10:00 am to 11:00 am ET. There will be time for questions from investors on the call although investors who prefer may wish to send questions in writing in advance of or during the call by emailing investor@yamana.com. Please see additional details relating to the call below.Wasamac Feasibility Study Update Call   Toll Free (North America): 1-800-806-5484Toronto...

TORONTO, July 12, 2021 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTCQX: RWBYF) (“RWB” or the “Company”), a multi-state cannabis operator and house of premium brands, is pleased to announce the release dates for the following financial statements, accompanying management discussion and analysis and related CEO and CFO certificates (collectively, the “Documents”):Fiscal Year Ended December 31, 2020: Thursday, July 22, 2021 (after market close) Q1 Ended March 31, 2021: Monday, July 26, 2021 (after market close) Management Conference Call: Tuesday, July 27, 2021 @ 4:30 PM eastern time (details to be included with an earnings press release on July 22, 2021)The Company would like to thank Shareholders for their patience while the Company contended with replacing their predecessor auditor MNP LLP (“MNP”)...

BOSTON, July 12, 2021 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral therapeutics for severe viral infections, today announced that Jean-Pierre Sommadossi, Ph.D., Founder, Chairman and Chief Executive Officer of Atea together with other members of the Atea management team, will participate in a fireside chat at the William Blair Biotech Focus Conference on Thursday, July 15, 2021 at 12:00 p.m. ET. A live webcast of the presentation will be available here and on the Company’s website at www.ateapharma.com. A replay of the webcast will be available for 90 days following the presentation. About Atea Pharmaceuticals Atea Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering, developing and...